Shigeru Matsuki

Title: Shigeru Matsuki: Innovator in Monoclonal Antibody Development

Introduction

Shigeru Matsuki is a prominent inventor based in Takasaki, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 3 patents to his name, Matsuki's work has advanced the detection of human G-CSF, a crucial component in medical diagnostics.

Latest Patents

Matsuki's latest patents include a method for selecting monoclonal antibodies for human G-CSF permitting. This invention relates to a high affinity monoclonal antibody for human G-CSF and an enzyme immunoassay utilizing this antibody. The innovation allows for the low-level detection of G-CSF in plasma, achieving sensitivity of equal to or less than 0.5 pg/ml without interference from human fluids. Another notable patent is for monoclonal antibodies and a method for the determination of human G-CSF. This invention enables the measurement of trace amounts of human G-CSF in body fluids from patients with hematological disorders, with a minimum detectable concentration of 0.5 pg/ml in plasma.

Career Highlights

Throughout his career, Matsuki has worked with notable companies such as Kirin-Amgen, Inc. and Kirin Beer Kabushiki Kaisha. His experience in these organizations has contributed to his expertise in the field of immunology and biotechnology.

Collaborations

Matsuki has collaborated with esteemed colleagues, including Takanori Ichikawa and Tomoaki Kuwaki. These partnerships have fostered innovation and advancement in their shared field of research.

Conclusion

Shigeru Matsuki's contributions to the development of monoclonal antibodies have had a significant impact on medical diagnostics. His innovative patents and collaborations highlight his dedication to advancing biotechnology.